Skip to content

DAWNDAY ONE BIOPHARMACEUTICALS I

CUSIP 23954D109 · common stock

No tracked investor reported shares of DAY ONE BIOPHARMACEUTICALS I (DAWN) for Q2 2026. 4 investors sold out this quarter, including Perceptive Advisors.

Holders · Q2 2026
0
New holders
0
Value held
$0
Quarter-end price (est.)
—

Investors holding DAWN · Q2 2026

No tracked investor reported shares this quarter.

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Perceptive Advisors0.74%1,755,799$37.6MEXIT
George Soros0.36%1,539,100$33MEXIT
Adar1 Capital Management0.06%49,923$1.1MEXIT
Ken Fisher0.00%43,698$936.9KEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q2 2026004$0—
Q1 2026430$72.6M$21.44
Q4 2025100$1.8M$9.32